Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Digoxin in Recurrent Prostate Cancer
NCT01162135Phase 2Completed
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center
- Start
- Sep 2010
- Primary completion
- Mar 2013
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of digoxin in prostate cancer (PCa), sponsored by Sidney Kimmel Comprehensive Cancer Center. Primary endpoint: Rate of Positive Prostate-Specific Antigen Doubling Time Outcome at 6 months. Started Sep 2010; status: completed.
02
Drugs
digoxin
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT01162135.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01162135.